RiverVest also invests in select later-stage venture opportunities to diversify risk and maximize portfolio returns. Established in 2000, RiverVest has funded 29 innovative life science companies and currently has assets under management of $208 million.
Medical diagnostics company commercializing the VerifyNow®
System for the assessment of platelet function in patients taking
Acquired by Gilead Sciences, Inc. (GILD)
Biopharmaceutical company developing novel therapeutics targeting
protein kinases for cancer and autoimmune/inflammatory diseases.
Cabrellis Pharmaceuticals Corporation, San Diego, CA
Acquired by Pharmion Corporation (PHRM)
Specialty pharmaceutical company developing therapies
for the treatment of cancer.
Acquired by Varian Medical Systems, Inc. (VAR)
Medical device company commercializing a proprietary
localization system to improve accuracy and management
of external beam radiation therapy.
Acquired by Boston Scientific Corporation (BSX)
Medical device company developing a next-generation
implantable defibrillator that is easier to implant and
does not require leads that attach to the heart.
Healthcare services company developing and operating
inpatient rehabilitation facilities in partnership with
leading acute care hospitals.
Acquired by Biogen Idec (BIIB)
Biotechnology company developing drugs that target a novel
pathway, HSP90 inhibition, for the treatment of cancer.
CyDex Pharmaceuticals, Inc., Overland, KS
Acquired by Ligand Pharmaceuticals Incorporated (LGND)
Specialty pharmaceutical company commercializing a
proprietary technology that improves drug solubility.
Acquired by Pfizer, Inc. (PFE)
Biopharmaceutical company focused on developing drugs
for the local treatment of fibrosis, including skin scarring.
Medical device company commercializing a novel stent
for the treatment of peripheral vascular disease.
Kaperio, Inc., St. Louis, MO
Seed-stage biopharmaceutical company focused
on cardiovascular disease.
Biotechnology company developing site-targeted drugs
and molecular imaging agents for cancer
and cardiovascular disease.
Biopharmaceutical company developing treatments for
metabolic diseases through non-systemically absorbed
compounds having targets within the lumen of the GI tract.
Medical device company developing an innovative automated
glucose measurement system to facilitate tight glycemic
control in hospital settings.
Acquired by C.R. Bard, Inc. (BCR)
Medical device company developing drug-coated balloon catheters
for the treatment of vascular disease.
Leading antibody therapeutics company with a focus on
autoimmune diseases and cancer.
Mpex Pharmaceuticals, San Diego, CA
Acquired by Aptalis
Biopharmaceutical company developing an inhaled antibiotic
for the treatment of cystic fibrosis and chronic obstructive
pulmonary disease, and new therapies to combat the growing
issue of antibiotic resistance.
Medical device company developing neurostimulation therapies
for patients with chronic pain including neuroma/residual limb
pain with future applications in chronic post-surgical pain.
Biopharmaceutical company developing novel drug therapies for
disorders of the inner and middle ear.
Acquired by Medtronic, Inc. (MDT)
(Formerly TissueLink) Medical device company commercializing
innovative radio-frequency electrosurgical instruments for orthopedic,
spine, and general surgery.
Securus Medical Group, Inc., Cleveland, OH
Medical device company developing clinical tools to monitor
core body temperature within body cavities in order to avoid
thermal injury to the tissue due to energy from various sources.
Medical device company commercializing novel stent systems
for the treatment of bifurcation lesions in coronary arteries.
Acquired by St. Jude Medical, Inc. (STJ)
Leading medical device company developing endovascular
and cardiology-related technologies.
IPO, then acquired by Cyclacel Pharmaceuticals (CYCC)
Biotechnology company developing novel cell-based
immunotherapeutic treatments for cancer and infectious disease.
Acquired by iCAD, Inc. (ICAD)
Medical device company commercializing electronic, miniaturized
x-ray technology for use in radiation oncology.